Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Meridian Bioscience (VIVO)

Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Meridian Bioscience 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 USA

www.meridianbioscience.com P: 513-271-3700 F: 513-271-3762

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.

Key Statistics

Overview:

Market Capitalization, $K 1,488,837
Enterprise Value, $K 1,432,387
Shares Outstanding, K 43,828
Annual Sales, $ 333,020 K
Annual Net Income, $ 42,460 K
Last Quarter Sales, $ 65,680 K
Last Quarter Net Income, $ 5,710 K
60-Month Beta 0.26
% of Insider Shareholders 2.30%
% of Institutional Shareholders 89.72%
Float, K 42,820
% Float 97.70%
Short Volume Ratio 0.42

Growth:

1-Year Return 56.91%
3-Year Return 335.51%
5-Year Return 138.39%
5-Year Revenue Growth 65.87%
5-Year Earnings Growth 105.97%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.20 on 11/22/22
Next Earnings Date 02/03/23
Earnings Per Share ttm 1.38
EPS Growth vs. Prev Qtr 17.65%
EPS Growth vs. Prev Year -13.04%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.125 on 02/01/19
Next Ex-Dividends Date 02/01/19
Dividend Payable Date 02/14/19
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 05/14/07

VIVO Ratios

Ratio
Price/Earnings ttm 24.62
Price/Earnings forward 41.18
Price/Earnings to Growth N/A
Return-on-Equity % 16.74%
Return-on-Assets % 13.09%
Profit Margin % 12.75%
Debt/Equity 0.07
Price/Sales 4.47
Price/Cash Flow 19.13
Price/Book 4.04
Book Value/Share 8.41
Interest Coverage 46.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar